Non-Myeloid Malignancy
2 clinical trials · Condition
◉ Watch Non-Myeloid Malignancy
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy (NCT04466137) | Xiamen Amoytop Biotech Co., Ltd. | 2020-10-16 |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (NCT04662892) | Coherus Oncology, Inc. | 2020-08-01 |
Track Non-Myeloid Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.